Skip to main content
Log in

Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Purpose

To analyze Gd-EOB-DTPA-enhanced magnetic resonance (MR) findings of nodules (low-grade dysplastic nodules—LGDNs; high-grade dysplastic nodules—HGDN, and hepatocellular carcinoma—HCC), histologically identified on cirrhotic, explanted livers.

Methods

IRB approval was obtained for this study. Thirty-four patients underwent Gd-EOB-DTPA-enhanced MR examinations (1.5T system), that included 20-min delayed hepatobiliary (HB) phase imaging, before undergoing orthotopic liver transplantation (OLT; mean time MR-OLT: 2.7 months). A total of 102 hepatic nodules were identified and analyzed at histopathological examination, and classified as LGDN, HGDN, and HCC. Two radiologists by consensus performed a quantitative (enhancement ratios, ERs) and a qualitative analyses of signal intensities of identified nodules on vascular dynamic phases (30–35 s after injection–arterial phase; 180–190 s after injection late phase) and on HB phases. Correlation between nodules MR patterns and histological classification was analyzed by means of dedicated statistical software.

Results

No differences were appreciable among ERs of HGDN and HCCs on HB phase (P > 0.001). Lesions’ enhancement on vascular dynamic and on HB phases significantly correlated to histological classification of nodules (P < 0.0001). Nodular hyperintensity on arterial phase and hypointensity on late phase were highly predictive for HCC (PPV 100%), with a moderate sensitivity (72.5%). Nodular hypointensity on HB phase was detected on 39/40 HCCs (sensitivity 97.5%) and in 21/30 HGDNs, whereas no LGDN showed it.

Conclusions

Hyperenhancement on arterial phase and hypointensity on late phase are the most specific clues for the diagnosis of HCC. Hypointensity on HB phase shows a PPV of 100% in suggesting nodular premalignancy/malignancy, independently from nodular dynamic vascular enhancement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022

    Article  PubMed  Google Scholar 

  2. Rhee H, Kim MJ, et al. (2012) Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria. JMRI 35:393–398

    Article  PubMed  Google Scholar 

  3. Bolondi L, Gaiani S, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42(1):27–34

    Article  PubMed  Google Scholar 

  4. Park YN, Yang CP, et al. (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662

    Article  PubMed  CAS  Google Scholar 

  5. Kim SR, Ikawa H, et al. (2007) Multistep hepatocarcinogenesis from a dysplastic nodule to well-differentiated hepatocellular carcinoma in a patient with alcohol-related liver cirrhosis. World J Gastroenterol 13(8):1271–1274

    PubMed  CAS  Google Scholar 

  6. Warwick R, Willatt JM, et al. (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247:311–333

    Article  Google Scholar 

  7. Huppertz A, Balzer T, et al. (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230(1):266–275

    Article  PubMed  Google Scholar 

  8. Golfieri R, Renzulli M, et al. (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis. Eur Radiol 21:1233–1242

    Article  PubMed  Google Scholar 

  9. Haradome H, Grazioli L, et al. (2011) Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging. J Magn Reson Imaging 34(1):69–78. doi:10.1002/jmri.22588

    Article  PubMed  Google Scholar 

  10. Kim JI, Lee JM, et al. (2008) The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol 43(3):202–210

    Article  PubMed  CAS  Google Scholar 

  11. Demetris AJ (1990) The pathology of the liver transplantation. Prog Liver Dis 9:687–709

    PubMed  CAS  Google Scholar 

  12. Couinaud C (1957) Le foie. Etudes anatomiques et chirurgicales. Paris: Masson

    Google Scholar 

  13. International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 49(2):658–664

    Article  Google Scholar 

  14. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver a study of 100 cases among 48, 900 necropsies. Cancer 7:462–503

    Article  PubMed  CAS  Google Scholar 

  15. Kim SH, Kim SH, et al. (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675–1681

    Article  PubMed  Google Scholar 

  16. Lim JH, Cho JM, et al. (2000) Displastic nodules in liver cirrhosis: evaluation of haemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 214:869–874

    PubMed  CAS  Google Scholar 

  17. Bartolozzi C, Crocetti L, et al. (2007) Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue specific MR contrast media. Eur Radiol 17:2519–2530

    Article  PubMed  Google Scholar 

  18. Chou CT, Chen YL, et al. (2010) Characterization of cirrhotic nodules with gadoxetic acid enhanced magnetic resonance imaging: the efficacy of hepatocyte phase imaging. J Magn Reson Imaging 32:895–902

    Article  PubMed  Google Scholar 

  19. Takayasu K, Muramatsu Y, et al. (1995) Early hepatocellular carcinoma: appearance at CT during arterial portography and CT arteriography with pathologic correlation. Radiology 194:101–105

    PubMed  CAS  Google Scholar 

  20. Narita M, Hatano E, et al. (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793–798

    Article  PubMed  CAS  Google Scholar 

  21. Saito K, Kotake F, et al. (2005) Gd-EOB.DTPA enhanced MRI for Hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Imaging Med Sci 4(1):1–9

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlo Bartolozzi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartolozzi, C., Battaglia, V., Bargellini, I. et al. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging 38, 290–296 (2013). https://doi.org/10.1007/s00261-012-9952-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-012-9952-9

Keywords

Navigation